Results 1-2 of 2 for cervical segment:8082578
- Written Answers — Department of Health: Medicinal Products (10 Nov 2021)
Paul Kehoe: 228. To ask the Minister for Health if public patients will have immediate access, without cost, to pembrolizumab for treatment of cervical cancer, if clinically recommended; and if he will make a statement on the matter. [54922/21]
- Written Answers — Department of Health: Medicinal Products (10 Nov 2021)
Stephen Donnelly: The HSE has put in place arrangements which will facilitate access to Pembrolizumab for cervical cancer patients, on a case-by-case basis in public hospitals, when a treating clinician determines that this is in the patient’s best interests. All prescribing decisions will be entirely a matter for the treating clinician, in line with patient safety protocols and the Medical...